ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
MTPA Announces Initiation of Open-Label Extension Study of Oral Edaravone in ALS
January 08, 2021Mitsubishi Tanabe Pharma America (MTPA) announced the initiation of a long-term safety extension study (MT-1186-A03) to the ongoing Phase 3 trial evaluating an investigational oral formulation of edaravone in patients with amyotrophic lateral sclerosis.
Pharma Sources Insight January 2025
